Codman Neuro’s REVIVE™ SE Thrombectomy Device Approved in China, South Korea and Taiwan

J&J’s Codman Neuro has gained a clutch of Far Eastern regulatory approvals for its REVIVE™ SE Thrombectomy Device for restoring blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.

Most read

Latest

^